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ABSTRACT 
The most emerging branch in pharmaceutical sciences is “nanotechnology.” Nanopharmaceuticals comprised of nano- sized products which can 
be transformed in numerous ways to improve their characteristics. Nanoparticles reveal enormous potential in tissue engineering, carriers in 
drug delivery, understanding of basic biological processes, imaging, sensing, disease diagnostics and therapeutics. Application of nontechnology 
in drug delivery and medicine has paved new pathways and opened many doors for providing customizable and safer treatment option. There 
are significant advantages of nanoparticles which make them more potential and effective than the conventional drug delivery system in terms 
of high stability, high specificity, high drug carrying capacity,ability for targeted release, controlled delivery, possibility to use in different route 
of administration and the capability to deliver both hydrophilic and hydrophobic drug molecules, site specific targeting. Nanomaterials like 
polymeric nanoparticles, magnetic nanoparticles, liposomes, carbon nanotubes, quantum dots, dendrimers, metallic nanoparticles, polymeric 
nanoparticles, etc. have brought about revolutionary changes in drug delivery systems and in many other fields. So that, through the 
manipulation of molecular size and surface properties, researchers are able to deliver drugs for longer period of time with less frequen t dosing 
and with greater precision and penetration in difficult to access tissues.The present chapter summarizes the types of nano pharmaceuticals with 
the properties, characterization and methods of preparation, advantages, and applications of nanoparticles in pharmaceutical and medical 
sector. 
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INTRODUCTION 
The emergence of nanoscience and nanotechnology, which is 
creation and utilization of materials and tools at the 
nanometer scale,has been a great influence on a number of 
industries and particularlythe pharmaceutical industry. 
Nanotechnology is a known field of research since last 
century. Delivering therapeutic compound to the desirable 
site is a major problem in treatment of many diseases. 
Conventional utilization of drugs is characterized by poor 
biodistribution, limited effectiveness, undesirable side 
effects, and lack of selectivity. Controlling drug delivery can 
potentially overcome these limitations by transporting drug 
to the place of action, so the drug delivery system provides 
protection against rapid degradation or clearance. It also 
enhances drug concentration in target tissues; therefore, 
lower doses of drug are required. Size reduction of targeted 
formulation and designing a suitable drug delivery system is 
a more fundamental and successful approach of 
nanotechnology. (1) 
Recent discovery in nanotechnology has proven that 
nanoparticle has a great potential as drug carriers. Size 
reduction methods and technologies yields different types of 
nanostructures that exhibit unique physicochemical and 
biological properties which enhance the performance in 
various dosage forms. The important factor of nanoparticle 
is that the size can influence the physiochemical properties 
of a substance. These nanoparticles showed characteristic 
colors and properties with the variation of size and shape, 
which can be utilized in bioimaging applications. (2) 
Nanotechnology is a multi-disciplinary scientific field 
applying engineering and manufacturing principles at the 
molecular level. Nanoparticles are solid, colloidal particles 
with size range from 10 nm to <1000 nm; however, for 
nanomedical application, the preferential size is less than 
200 nm. “Nano” word is originated from Latin word, which 
means dwarf. Ideal size range offered by nanotechnology 
refers to one thousand millionth of a particular unit thus 
nanometer is one thousand millionth of a meter (i.e. 1 nm = 
10 −9 m). Nanoparticless are not simple molecules itself and 
therefore composed of three layers i.e. (a) The surface layer, 
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which may be functionalized with a variety of small 
molecules, metal ions, surfactants and polymers. (b) The 
shell layer, which is chemically different material from the 
core in all aspects, and (c) The core, which is essentially the 
central portion of the nanoparticle and usually refers the 
nanoparticle itself. (3) In this review article, we aim to focus 
on different types, advantages, preparation, characteristics 
and applications with future scope of nanoparticles. 
VARIOUS TYPES OF PHARMACEUTICAL 
NANOSYSTEMS 
There are many types of nanoparticles platforms with 
differing size, shape, compositions, and functions. They are 
mentioned below. 
1. Liposomes 
Liposomes are spherical vesicles that contain a single or 
multiple bilayered structures of lipids that self-assemble in 
aqueous systems. Their size ranges from 50-100 
nm.Advantages of liposomes are their diverse range of 
compositions, abilities to carry and protect many types of 
biomolecules, as well as theirbiocompatibility and 
biodegradability.They also have good entrapment efficiency. 
They are long circulatory, offer passive and active delivery of 
gene, protein and peptide can also be functionalized with 
targeting ligands to increase the accumulation of diagnostic 
and therapeutic agents within desired cells. (1) 
2. Solid lipid nanoparticles 
The use and scope of solid lipid nanoparticleis increasing 
day by day in pharmaceuticals because it represent an 
alternative and suitable system to traditional colloidal 
carriers such asemulsions, liposomes and polymeric micro 
andnanoparticles. They have size 50–1000 nm. (4) They are 
made up of solid lipids (high melting fat matrix), are 
developed to conquer the weaknesses such as polymer 
degradation and cytotoxicity, lack of a suitable large scale 
production method, inferior stability, drug leakage and 
fusion, phospholipid degradation, high production cost, and 
sterilization problems) their aim is to provide 
biocompatibility, storage stability and to prevent the 
incorporated drug from degradation. (5) The solid core of 
solid lipid nanoparticle is hydrophobic with a monolayer 
coating of phospholipids and the drug is usually dispersed or 
dissolved in the core. Widely used in targeted brain drug 
delivery, anticancer drug delivery, topical use, cosmetics, 
anti-tubercular chemotherapy, adjuvant for vaccines. (6) 
3. Carbon nanotubes 
They are cylindrical molecules which having size of 0.5–3 
nm indiameterand20–1000 nm inlength. Third allotropic 
crystallineform of carbon sheets either single layer or 
multiplelayer nanotube. They haveremarkable strength 
andunique mechanical, thermal and electrical 
properties(conducting, semi conducting,or insulating). Their 
functions are enhanced solubility, penetration to cell 
cytoplasm and to nucleus, as carrier for gene delivery, 
peptide delivery. They are used as diagnostic tool in cancer 
at their early stage. (7) 
4. Dendrimers 
Dendrimers arebranched macromolecules made up of 
synthetic or natural elements including amino acids, sugars, 
and nucleotides.They have a central core, interior layers of 
branches, and an exterior surface. They are highly branched, 
nearly, monodisperse polymer system produced by 
controlled polymerization. Small molecules in the cavities of 
the cores are loaded in dendrimersthrough chemical linkage, 
hydrogen bond, and or hydrophobic interaction. They have 
size <10 nm. They are useful incontrolled delivery of 
bioactives, targeted delivery of bioactives to macrophages 
and liver targeting. (1) 
5. Polymeric nanoparticles 
Polymeric nanoparticles are formulated through block-
copolymers of different hydrophobicity.These copolymers 
spontaneously assemble into a core-shell micelle formation 
in an aqueous environment. They are biocompatible and 
biodegradable. They are especially formulated to 
encapsulate hydrophilic and/or hydrophobic small drug 
molecules, proteins and nucleic acid macromaoleculesans 
offer complete drug protection. They have particle size 10-
1000 nm. Excellent carrier for controlled and sustained 
delivery of drugs, stealth and surface modified nanoparticles 
can be used for active and passive delivery of bioactives. (8) 
6. Polymeric micelles 
Polymeric micelles are nanosized core/shell structures 
formed by amphiphilic block copolymers. They have particle 
size 10-100 nm. The properties likehigh drug entrapment, 
payload, biostability,  small size, unique nanoscopic 
architecture, enhance the solubilization of poorly soluble 
molecules and ability of block copolymer micelles to be 
tailored for good compatibility with the drug of choice are all 
highly desirable properties for a drug delivery system. (9) 
7. Metallic nanoparticles 
Metallic nanoparticles such as iron oxide, gold and silver 
nanoparticles, nanoshells, and nanocages have been 
continuously used and modified to enable their use as a 
diagnostic and therapeutic agent. Generally it has particle 
size <100. (8) 
Gold nanoparticles 
Gold Nanoparticles Colloidal gold, also known as gold 
nanoparticles, is a suspension (or colloid) of nanometer-
sized particles of gold. Gold nanoparticles offer many size 
and shape dependent optical and chemical properties, 
biocompatibility, and facile surface modification. Gold NPs 
can strongly enhance optical processes such as light 
absorption, scattering, fluorescence, and surface-enhanced 
Raman scattering (SERS) due to the unique interaction of the 
free electrons in the NP with light. Their probes are used to 
detect cancer biomarkers and heart diseases and have 
various biomedical and therapeutic applications. (10) 
8. Iron Oxide Nanoparticles 
Iron (III) oxide (Fe2O3) nanoparticle is a mangnetic 
nanoparticle in reddish brown, inorganic compound which is 
paramagnetic in nature and also one of the three main 
oxides of iron, while other two being FeO and Fe3O4. Due to 
their ultrafine size, magnetic properties, and 
biocompatibility, paramagnetic iron oxide nanoparticles are 
potentially used in various biomedical applications, such as 
enhanced resolution contrast agents for MRI, targeted drug 
delivery and imaging, hyperthermia, gene therapy, stem cell 
tracking, molecular/cellular tracking, magnetic separation 
technologies. (10) 
9. Quantum dots 
Quantum dots are semiconductor particles that are 2- 10 nm 
in diameter. Technically they are ‘small crystals containing a 
variable number of electrons that occupy well-defined, 
discrete quantum states and have electronic properties 
intermediate between bulk and discrete fundamental 
particle. They consist of semiconductor core, over coated by 
a shell, and a cap enabling improved solubility in aqueous 
buffers. Quantum dots are used in multitasking purposes 
such as medical diagnostics, drug delivery andgene 
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therapy.Toxicity is a major obstacle when considering 
quantum dots for various biomedical applications. (11) 
PROPERTIES OF NANOPARTICLES 
• Decrease drug resistance 
• Decrease toxicity  
• Increase oral bioavailability 
• Enhance rate of dissolution 
• Enhance solubility 
• Increase the stability of drug and formulation 
• Increase drug targeting ability 
• Decreased patient-to-patient variability and increase 
patient compliance 
• Increase surface area 
• Less amount of dose required (8) 
CHARACTERIZATION OF NANOPARTICLE DRUG 
FORMULATIONS 
Nanoparticles can enter the human body, via three main 
route, direct injection, inhalation and oral intake. If 
something is recognized as foreign, macrophages will engulf 
and clear it from the body. This tends to be the struggle with 
nanoparticle based drug delivery; however, clearance can be 
influenced by the size and surface characteristics of 
particles, which is discussed in following subsection. 
Surface Charge 
Surface charge and intensity determines the interaction of 
nanoparticles with the biological environment as well as 
their electrostatic interaction with bioactive compounds. 
Stability of colloidal material is usually analyzed through 
zeta potential of nanoparticles. Zeta potential is an indirect 
measure of the surface charge. (8) 
Surface properties 
In order to create an optimum nanoparticle drug delivery 
system, the incorporation of appropriate targeting ligands, 
surface curvature and reactivity is important to address the 
prevention of aggregation, stability, and receptor binding 
and subsequent pharmacological effects of the drug. Surface 
properties primarily detect the agglomeration state of 
particles and colloidal properties therefore their effective 
size, especially under physiological conditions. (12) 
Drug loading capacity and release 
The size and surface properties of nanoparticles have been 
explored to optimize bioavailability, decrease clearance, and 
increase stability. By controlling these characteristics, it is 
possible to get the drug to tissues in the body. However, this 
whole practice is useless if the drug cannot then be released 
from the nanoparticle matrix. Depending on the type of 
nanoparticle being used, the release of drug will differ. The 
release of drug from the nanoparticle-based formulation 
depends on many factors including, pH, temperature, drug 
solubility, desorption of the surface-bound or adsorbed 
drug, drug diffusion through the nanoparticle matrix, 
nanoparticle matrix swelling and erosion. Various 
techniques such as UV spectroscopy or high performance 
liquid chromatography after ultracentrifugation, ultra 
filtration, gel filtration, or centrifugal ultrafiltration are used 
to determine this parameter. (13) 
Particle size 
As particles size gets smaller, their surface area to volume 
ratio gets larger. This would imply that more of the drug is 
closer to the surface of the particle compared to a larger 
molecule. Being at or near the surface would lead to faster 
drug release. The shape and size of nanoparticles affects how 
cell in the body react to them and thus dictate their 
distribution, toxicity, and targeting ability. (3) 
 
Table 1: Various methods and characterization tools for nanoparticles. (8) 
S.N. Parameter Characterization method 
1 Carrier-drug interaction Diffential scanning calorimetry 
2 Charge determination Laser Doppler Anemometry & Zeta potentiometer 
3 Chemical analysis of surface Static secondary ion mass spectrometry & Sorptometer 
4 Drug stability Bioassay of drug extacted from Nanoparticles& Chemical analysis of drug 
5 Nanoparticle dispersion stability Critical flocculation temperature (CFT)  
 Particle size and distribution Atomic force microscopy 
Laser defractometry 
Photon correlation spectroscopy (PCS) 
Scanning electron microscopy 
Transmission electron microscopy 
6 Release profile In vitro release characteristics under physiologic and sink conditions 
7 Surface hydrophobicity Rose Bengal(dye) binding 
Water contact angle measurement 
X-ray photoelectron spectroscopy 
 
 
METHODS OF PREPARATION OF NANOPARTICLES 
The selection of appropriate method for the preparation of 
nanoparticles depends on the physicochemical properties of 
polymer and drug to be loaded. Nanoparticles can be 
prepared from a variety of materials such as proteins, 
polysaccharides, lipids, natural and synthetic polymers. 
Selection of matrix material is depends on following factors. 
(8) 
• Surface characteristics (charge and permeability) 
• Aqueous solubility and stability of the drug 
• Size of nanoparticles required 
• Biocompatibility and toxicity 
• Antigenicity of the final product 
• Drug release profile desired 
• Degree of biodegradability 
1) Solvent Emulsification-Evaporation Method 
This method involves two steps. First step is emulsification 
of the polymer solution into an aqueous phase and second 
step is evaporation of polymer solvent, inducing polymer 
precipitation. This method is based on the solubility of 
polymer and hydrophobic drug since both polymer and 
Soaker et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(3):543-548 
ISSN: 2250-1177                                                                                    [546]                                                                                    CODEN (USA): JDDTAO 
hydrophobic drug are dissolved in an organic solvent. 
Mixture obtained from polymer and drug solution is then 
emulsified in an aqueous solution. This aqueous solution 
contains surfactant or emulsifying agent to form oil in water 
(o/w) emulsion. (15) Under appropriate conditions, the 
subsequent evaporation of the organic solvent by 
continuous stirring or reducing the pressure induces 
polymer aggregation in the form of nanoparticles. In order to 
produce small particle size, ultrasonication or high-speed 
homogenization may be often employed.  Drugs with 
lipophilic characteristics are then incorporated into the 
organic phase. (16) Purification stages can be performed by 
recovering polymer nanoparticles by ultracentrifugation and 
consecutive washes with distilled water to remove the 
stabilizer and release the drug. (17) 
2) Emulsification-Diffusion Method 
Emulsification-Diffusion Method thermodynamic principles 
that involve, firstly, the use of partially water-miscible 
solvents in equilibrium with another immiscible solvent, 
generally water (saturation). This step is performed to avoid 
mass transference during the process. (18) In general, the 
method consists of preparing a conventional oil-in-water 
emulsion (1:2).The internal organic phase includes 
preparing the drug or drugs for encapsulation and the 
polymer, both dissolved in the water-saturated solvent. The 
external aqueous phase consists of one or more hydrophilic 
stabilizers dissolved in the solvent-saturated water. The 
emulsion is formed conventionally by adding the organic 
phase into the aqueous phase under mechanical stirring.   
The diffusion can be performed by using two ways. The first 
is fast diffusion by dilution with water. In this case, the 
amount of water required should be sufficient to dissolve the 
inner-organic phase while the second comprises rapid 
displacement of the solvent from the internal into the 
external phase by evaporation under reduced pressure, 
depending on the boiling point of the solvent.  Sometimes 
this modality is denominated “emulsification-solvent 
displacement.” In both cases, the presence of a nonsolvent 
medium gives rise to polymer aggregation in nanoparticles if 
the stabilizing effect is suitable. (19) 
This technique provides several advantages, such as  
• High encapsulation efficiencies (generally 70 %) 
• No need for homogenization 
• Highbatch-to-batch reproducibility 
• Ease of scale-up 
•Narrow size distribution (20) 
3) Double Emulsion and Evaporation Method 
Double emulsion also termed as emulsion of emulsion, are 
complex system, in which the dropletsof dispersed phase 
themselves comprises even small of dispersed phase. Double 
emulsion (DE) droplets are mostly polydispersed in size. To 
overcome the limitation ofpoor entrapment of hydrophilic 
drugs double emulsion technique is employed. There are 
two common types of double emulsion; water-oil-water (w/ 
o/w) and oil-water-oil (o/w/o).(21) This involves the addition 
of aqueous drug solutions to organic polymer solution under 
vigorous stirring to form w/o emulsions. This w/o emulsion 
is added into second aqueous phase with continuous stirring 
to form the w/o/w emulsion. The solvent removal in 
emulsion is done by evaporation and nano particles can be 
isolated by centrifugation at high speed. The stability and 
release properties of double emulsions can be greatly 
improved by a change in the type and concentration of 
stabilizer employed in the system. Such systems are 
biocompatible, biodegradable and versatile with respect to 
different oils and emulsifiers being employed. Both 
hydrophobic and hydrophilic kinds of drugs can be 
protectively encapsulated separately and simultaneously. 
Some limitations are also linked with this technique are 
large and non-uniform particles (polydisperse), two step 
process, leakage of the hydrophilic active into external 
aqueous phase, difficult to scale up. (22) 
4) Solvent Displacement/Precipitation Method 
The solvent displacement method is a convenient, 
reproducible, fast, and economic one-step manufacturing 
process for the preparation of monodisperse, polymeric 
nanoparticles in a size range of approximately 50–300nm. 
This method is more suitable for poorly soluble drugs. This 
technique requires the use of amphiphilic organic solvents 
that are completely miscible with water, for example 
acetone. Progressive addition of polymer dissolved in 
acetone to an aqueous phase under stirring leads to the 
formation of colloidal particles.  This step is followed by the 
removal of solvent from the suspensions under reduced 
pressure. (23) Particles size is dependent on the extent of 
addition of the organic phase into the aqueous phase. It was 
also found that as the mixing rate of the two phase increases, 
particles size and drug entrapment decreases. Regulating the 
concentration of polymer in the organic phase was reported 
to be useful in the production of smaller sized nanospheres. 
(20) 
5) Coacervation or Ionic Gelation Method 
Inotropic gelation technique was first reported by Calvo and 
has been widely examined and developed by Janes. 
Biodegradable polymers such as gelatin and sodium alginate 
have been focused now to yield biodegradable nanoparticles 
having features like biocompatibility and low toxicity. 
Chitosan can be dissolved in acetic acid in the absence or 
presence of stabilizing agent, such as poloxamer, which can 
be added in the chitosan solution before or after the addition 
of polyanion. (24) Polyanion or anionic polymers was then 
added and nanoparticles were spontaneously formed. 
Coacervates are formed by existence of strong electrostatic 
interaction between two aqueous phases. In contrast ionic 
gelation involves the material undergoing transition from 
liquid to gel due to ionic interaction conditions at room 
temperature.(25) This method has some limitations such as 
defects such as improper surface morphology, fragile 
particulate system, high dispersibility index and lack of 
proper surface modification sites to attach functional 
moieties. (26) 
6) Supercritical Fluid Technology 
The methods mentioned above use organic solvents which 
are hazardous to the environment as well as to physiological 
systems. Therefore, there is requirement of suitable 
technology which avoid the usage of organic solvents or any 
other ingredient hazardous to health. The supercritical fluid 
technology has been investigated as an alternative to 
prepare biodegradable micro- and nanoparticles and it is 
environmentally safe.Supercritical fluid technologyreplaces 
organic solvents in a number of chemical processes. 
Supercritical fluids are those fluids which are at a 
temperature above its critical temperature remains in a 
single phase regardless of pressure. (27) CO2(SCCO2) is the 
most widely used supercritical fluid because of its mild 
critical conditions, non-flammability, low price and 
nontoxicity.However, in recent years the materials 
processing which covers all the set of processes is being 
carried out using not only the scH2O or scCO2, but also 
supercritical ammonia, supercritical amines, supercritical 
alcohols, etc. SCF technology produces nanoparticles with 
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solvent levels below 25 ppm. There are several variants in 
SCF technology like static supercritical fluid process (SSF), 
rapid expansion of supercritical solutions (RESS), particles 
from gas-saturated solutions (PGSS),supercritical 
antisolvent process (SAS), supercritical fluids drying (SCFD), 
supercritical fluid extraction emulsions(SFEE),etc. (28) 
APPLICATIONS OF NANOPARTICLES IN 
PHARMACEUTICAL DEVELOPMENT AND DRUF 
DELIVERY SYSTEM 
1) Nanoparticles for Gene Delivery 
Gene therapy is an approach of treating disease by either 
replacing a defective gene or modifying the expression of a 
gene by introducing genetic material/DNA into the cells. 
Nanoparticles emerged as the most promising vehicles for 
clinical gene therapy due to their size, shape, surface, and 
biological behaviors. Gene therapy has drawn significant 
attention as a promising strategy for specific treatment of 
numerous gene-associated human diseases ranging from 
cancer, hemophilia, hypercholesterolemia, neuro-
degenerative diseases to autoimmune diseases. This strategy 
is to introduce genes into the target pathological tissues or 
cells by altering the expression of the endogenous genes to 
cure or prevent the progression of the related disease. (29) 
The challenges in gene delivery are encapsulation efficiency, 
stability of nanoparticles, degradation in blood circulation 
and endocytosisby target cells, endosomal escape, delivery 
efficiency, and toxicity of pharmacology. To overcome these 
obstacles, many types of nanoparticles have been evaluated 
as gene carriers, which include lipid-based nanoparticles, 
polymer-based nanoparticlesand inorganic nanoparticles. 
The recent example of polynucleotide vaccine producing the 
antigenic protein within the vicinity of professional antigen 
presenting cells to initiate immune response.Polynucleotide 
vaccines are composed of a key ingredient called as DNA can 
be produced economically and has much better storage and 
handling properties than the ingredients of the majority of 
protein-based vaccines. (30) 
2) Nanoparticles for Drug Delivery into the Brain 
One of the most challenging obstacles for an effective 
treatment of CNS related disorders is the low efficiency 
penetration of drugs to CNS due to the presence of the BBB. 
The BBB is a dynamic barrier which protects the brain 
against invading organism and unwanted substances. Small 
hydrophilic compounds with a mass lower than 150 Da and 
highly hydrophobic compounds with a mass lower than 
400–600 Da are able to cross the BBB by passive 
diffusion.To achieve this, formation of nano sized particle is 
important. Nanoparticles should be non-toxic, biodegradable 
and biocompatible, non-inflammatory and non-
immunogenic. (31) There are no effective therapies for many 
diseases include neurodegeneration(e.g., amyotrophic 
lateral sclerosis, Alzheimer’s, Parkinson’s, Huntington 
disease, and Prion disease), genetic deficiencies and several 
types ofbrain cancer.Nanotechnology has shown to be useful 
toolfor crossing the BBB, a key aspect for an effective 
treatment of neurodegenerative disorders, offering a brain 
target delivery and a sustained release profile. (32) 
3) Nanoparticles for targeted imaging 
Molecular imaging refers to the development of molecular 
probes for the visualization of the cellular function, 
characterization and the measurement of molecular 
processes in living organisms at the cellular and molecular 
level without perturbing them. On conjugation with tumor 
targeting ligands (e.g., peptides, small organic molecules, 
antibodies, etc.), nanoparticles can be successfully used as 
tumor-specificprobes with high specificity. Emerging 
nanoparticle technologiesare joined by intense development 
of imaging modalities to assist with disease detection. (33) 
Particle charge, size, shape and hydrophilicity remain among 
the most important properties of nanoparticles for effective 
delivery to the desired target. Nanomaterialssuch as gold 
nanoparticles, quantum dots, iron oxide nanoparticles and 
dendrimers are widely used in biomedical imaging 
applications. Utilization of gold nanoparticles as 
ultrasensitive fluorescent probes to detect cancer 
biomarkers in human blood is highly sensitive approach and 
direct detection of viral or bacterial DNA is possible. Metallic 
nanoparticles possess immense potential as X-ray contrast 
imaging agents owing to their potent X-ray absorption and 
low toxicity profiles observed over short durations in 
animals. (34) 
4) Nanoparticle delivery to subcellular organelles 
Targeting of the drug to cells or tissue of choice is the 
potential area in drug delivery. In delivery systems targeting 
is the ability to direct the drug-loaded system to desirable 
site. Targeted nanoparticles can bind to targets situated on 
the cell surface and enter the cell through endocytosis. There 
are two mechanisms involved in this process. (8) 
1) Passive targeting of nanoparticles to a particular 
organelle by varying characteristicsof nanoparticles such as 
size, shape, and composition. In passive targeting ligand–
receptor interactions can be highly selective; hence targeting 
at the site of interest is possible. Example of passive 
targeting is the preferential accumulation of 
chemotherapeutic agents in solid tumors. 2) Active targeting 
allows the surface functionalization of drug carriers with 
ligands that are selectively recognized by receptors on the 
surface of the cells of interest. Nanoparticles can be 
significantly used in targeted drug delivery at the site of 
disease to improve the drug bioavailability, targeting of 
drugs to a specific site and to improve the uptake of poorly 
soluble drugs. (35) 
CONCLUSION 
Nanotechnology and nanoparticles have a wide range of 
applications in biology and medicine. As mentioned above, 
nanoparticles enables novel techniques in imaging, sensing 
and it is best suited to creating systems that can better 
deliver drugs to tiny areas within the body. Nanoparticle 
drug delivery system will helps to lower drug toxicity, 
reduced cost of treatments, improved bioavailability. Nano-
enabled drug delivery also makes it possible for drugs to 
permeate through cell walls, which is of critical importance 
to the expected growth of genetic medicine over the next few 
years. Some recently found health risk evidences limits their 
utilization in pharmacy and medical field. Some concerning 
issues like safety, bioethical issues, toxicity hazards, 
physiological and pharmaceutical challenges should be 
overcome. We are still lacking sufficient data and guidelines 
regarding safe use of these nanotechnology based devices 
and materials and medications. In future expansion of 
nanotechnology is likely to affect just about every route of 
administration from oral to injectable and offer significant 
impact on drug delivery sector. 
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